Blackburn
Blackburn
Blackburn, Lancashire, United Kingdom5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Chemo Brain Prehab Project | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Not applicable | 2026-09-09 | NCT07341217 | |
| Stopping Aminosalicylate Therapy in Inactive Crohn's Disease | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Active, not recruiting | Phase 4 | 2026-05-28 | NCT03261206 | |
| Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System | Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, avascular necrosis, bone disorder, connective tissue disorder, immune system disorder, musculoskeletal system disorder, osteoarthritis, osteonecrosis, rheumatic disorder, rheumatoid arthritis | Active, not recruiting | Not stated | 2026-04-28 | NCT01480440 | |
| The MANTRA Trial (MANdibular TRauma and Antibiotic Use) | Craniocerebral Trauma, Facial Injuries, Infections, Mandibular Fractures, Maxillofacial Injuries, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Skull Fractures, Surgical Wound Infection, Wound Infection, bone fracture, injury, jaw fracture, nervous system disorder, nervous system injury | Recruiting | Phase 3 | 2026-01-22 | NCT05964140 | |
| Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate adenocarcinoma, prostate cancer, prostate disorder | Active, not recruiting | Phase 3 | 2025-12-18 | NCT04446117 |